Key Highlights

  • Interface's quarterly Dividend of $0.03 per share trades ex-date September 4, 2026, payable September 18, yielding approximately 0.33%.
  • Q2 2026 net sales rose 5.4% to $395.7 million, with Net Income up 58% to $51.4 million, or $0.88 per diluted share.
  • A $15.6 million IEEPA Tariff refund contributed 393 basis points to adjusted gross margin, alongside 131 basis points of genuine operational improvement.
  • Healthcare billings grew 19% globally, and the company raised full-year 2026 guidance on strong Backlog and order momentum.

Interface's (Nasdaq:TILE) quarterly dividend of $0.03 per share yields a modest 0.33%. The more relevant story behind this quarter's strong results is separating what's temporary from what's structural: a one-time tariff refund boosted margins meaningfully, but genuine operational improvement and broad-based Demand growth, particularly in healthcare, suggest the underlying Business is also strengthening.

Dividend Program and Shareholder Returns

Interface's Board declared a regular quarterly Cash Dividend of $0.03 per share, payable September 18, 2026, to shareholders of record September 4, trading ex-dividend the same date and yielding approximately 0.33%. This follows two dividend increases within the past year, first from $0.02 to $0.03 in February 2026 and previously from $0.01 to $0.02, reflecting management's stated confidence in the business and focus on disciplined Capital allocation. The company also repurchased $8.8 million of stock in Q2, or approximately $21 million year to date, indicating a shareholder-return approach that combines a growing but still modest dividend with active buybacks.

About the Company

Interface is a global flooring company serving commercial and residential markets through its Interface carpet tile and LVT, nora rubber flooring, and FLOR premium area rugs brands. The company sells primarily through architects, designers, contractors, and commercial flooring channels, differentiating itself through design, modular flooring technology, and sustainability initiatives, with a business influenced by commercial construction, office occupancy, and healthcare construction activity.

Financial Performance Behind the Payout

Interface reported Q2 2026 net sales of $395.7 million, up 5.4% year over year and 3.8% on a currency-neutral basis. Adjusted gross profit Margin increased 524 basis points to 45.0%, including 393 basis points from a $15.6 million IEEPA tariff refund and 131 basis points from operational improvements including higher sales volumes and Manufacturing efficiency initiatives. GAAP net income was $51.4 million, or $0.88 per diluted share, compared with $32.6 million, or $0.55, a year earlier. For the first six months, net sales reached $726.7 million and net income was $75.0 million, or $1.28 per diluted share. Healthcare billings increased 19% globally, while corporate-office billings rose 5%.

A Tariff Windfall Arrived Alongside Genuine Operational Gains

The central analytical distinction for Interface this quarter is separating the one-time tariff refund from durable operational improvement. The $15.6 million refund, recognized as a reduction to cost of sales after a Supreme Court ruling invalidated certain IEEPA tariffs, contributed roughly $0.19 to adjusted EPS and will not recur, while the 131 basis points of margin improvement from manufacturing efficiency and higher sales volumes reflects a more sustainable trend. Healthcare's 19% billings growth, following 28% growth in the prior-year quarter, suggests this end market remains a particularly resilient demand driver for Interface. Management's decision to raise full-year guidance despite explicitly assuming no further tariff refunds signals confidence that operational and demand improvements can stand on their own once the one-time benefit fully laps.

Outlook

Interface's dividend is well supported by broad-based demand growth and genuine operational improvement, even after excluding the one-time tariff refund that boosted this quarter's margins. Investors should watch currency-neutral sales growth, healthcare and corporate-office billings trends, manufacturing productivity gains, and margin performance once the tariff refund fully laps from comparisons.